OncLive® Hosts State of the Science Summit: Hematologic Malignancies

The program will also deliver updates from American Society of Hematology 2017

CRANBURY, N.J.--()--OncLive®, the leading digital provider of resources and information for oncology professionals, will present State of the Science Summit: Hematologic Malignancies on March 24 at 8:30 a.m. at The Westin New York Grand Central. Attendees will also receive updates from the American Society of Hematology (ASH) 2017 annual meeting. The program will be chaired by internationally renowned clinician and researcher, Andre H. Goy, M.D., M.S., chairman and director, chief of lymphoma, and director of clinical and translational cancer research, John Theurer Cancer Center; chief science officer and director of research and innovation, Regional Cancer Care Associates; and professor of medicine, Georgetown University School of Medicine.

Attendees will gain knowledge from lectures and discussions featuring expert presenters. Topics that will be discussed include multiple myeloma, diffuse large cell lymphoma, treatment of B-cell lymphomas and T-cell lymphoma. Attendees will also get insight on the latest scientific advances in hematologic malignancies during the Peer Exchange® panel discussions.

Presenters for the program include:

  • Noa Biran, M.D., hematology specialist, myeloma division, John Theurer Cancer Center
  • Stuart Goldberg, M.D., hematologist, Hackensack University Medical Center
  • Paul Hamlin, M.D., chief, Basking Ridge Medical Oncology Service, Memorial Sloan Kettering Cancer Center
  • C. Ola Landgren, M.D., Ph.D., hematologic oncologist, chief, myeloma service, Memorial Sloan Kettering Cancer Center
  • Lori Leslie, M.D., hematology and medical oncology specialist, John Theurer Cancer Center
  • Michael J. Mauro, M.D., hematologist, leader, myeloproliferative neoplasms program, Memorial Sloan Kettering Cancer Center
  • Alison J. Moskowitz, M.D., medical oncologist, clinical director, lymphoma inpatient unit, Memorial Sloan Kettering Cancer Center
  • Alan Skarbnik, M.D., physician, department of bone marrow transplantation, department of lymphoma, John Theurer Cancer Center
  • Koen van Besien, M.D., Ph.D., director, stem cell transplant program, and professor of medicine, Weill Cornell Medical College; attending physician, New York-Presbyterian Hospital

State of the Science Summit is a premier conference series hosted by OncLive® that features medical experts from across the nation. Aiming to discuss current treatment options, each summit meeting integrates academic and community-based physicians and health care professionals from across key disciplines that range from medical and surgical oncology to hematology.

Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit www.onclive.com/meetings/soss or contact Allison Cooper at ACooper@curetoday.com.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for MJH Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.

Contacts

OncLive® Media
Theresa Burek, 609-325-4811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777, ext. 851
sverma@mjhassoc.com

Release Summary

OncLive® Hosts State of the Science Summit™: Hematologic Malignancies

Contacts

OncLive® Media
Theresa Burek, 609-325-4811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777, ext. 851
sverma@mjhassoc.com